BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2919672)

  • 1. Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats.
    Esplugues JV; Whittle BJ
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G275-82. PubMed ID: 2919672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP; Nourshargh S; Hellewell PG; Williams TJ
    Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
    Dyson MC; Bellan JA; Minkes RK; Beckerman RC; Wegmann MJ; Braquet P; McNamara DB; Kadowitz PJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1320-7. PubMed ID: 2175802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.
    Esplugues JV; Whittle BJ
    Br J Pharmacol; 1988 Jan; 93(1):222-8. PubMed ID: 3349230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of thromboxane A2 receptor antagonism on pulmonary vasoconstrictor responses.
    Bradley LM; Stambouly JJ; Czaja JF; Goldstein RE
    Pediatr Res; 1989 Sep; 26(3):175-9. PubMed ID: 2587116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of prostaglandins and 5-hydroxytryptamine in the contractile effect of platelet-activating factor in rat isolated gastric corpus.
    Martínez-Cuesta MA; Barrachina MD; Moreno L; Calatayud S; Esplugues J
    J Pharm Pharmacol; 1996 Sep; 48(9):955-8. PubMed ID: 8910861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of bronchoconstrictor responses to platelet-activating factor in the cat.
    Underwood DC; Kadowitz PJ
    J Appl Physiol (1985); 1989 Jul; 67(1):377-82. PubMed ID: 2759966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat.
    Boughton-Smith NK; Hutcheson I; Whittle BJ
    Prostaglandins; 1989 Sep; 38(3):319-33. PubMed ID: 2506613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of hypotension produced by platelet-activating factor.
    Laurindo FR; Goldstein RE; Davenport NJ; Ezra D; Feuerstein GZ
    J Appl Physiol (1985); 1989 Jun; 66(6):2681-90. PubMed ID: 2745330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor (PAF) has no direct effect on rat intracerebral arterioles in vitro.
    Edwards RM; Trizna W; Feuerstein G
    J Lipid Mediat; 1991; 3(2):161-5. PubMed ID: 1797151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of PAF-induced death in mice.
    Myers AK; Nakanishi T; Ramwell P
    Prostaglandins; 1988 Mar; 35(3):447-58. PubMed ID: 3131837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of platelet-activating factor (PAF) in endotoxin-induced intestinal motor disturbances in rats.
    Pons L; Droy-Lefaix MT; Braquet P; Buéno L
    Life Sci; 1989; 45(6):533-41. PubMed ID: 2570338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.
    Sirois MG; de Lima WT; de Brum Fernandes AJ; Johnson RJ; Plante GE; Sirois P
    Br J Pharmacol; 1994 Apr; 111(4):1111-6. PubMed ID: 8032597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.
    Schumacher WA; Steinbacher TE
    J Lipid Mediat; 1991; 4(1):97-110. PubMed ID: 1832573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H; Demos M; Wong A
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf.
    Esplugues JV; Whittle BJ; Moncada S
    Br J Pharmacol; 1989 Jun; 97(2):579-85. PubMed ID: 2758231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
    Wu MS; Biftu T; Doebber TW
    J Pharmacol Exp Ther; 1986 Dec; 239(3):841-5. PubMed ID: 3795043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism.
    Hatakeyama K; Yano S; Watanabe K
    Jpn J Pharmacol; 1991 Jul; 56(3):271-7. PubMed ID: 1910120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet-activating factor (PAF) and prostaglandins in colonic motor and secretory disturbances induced by Escherichia coli endotoxin in conscious rats.
    Pons L; Droy-Lefaix MT; Buéno L
    Prostaglandins; 1994 Feb; 47(2):123-36. PubMed ID: 8016383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.
    Wang J; Dunn MJ
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1283-9. PubMed ID: 2827506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.